This policy addresses the ongoing delivery and regulation of COVID-19 and influenza vaccination programmes in the UK, managed by the Department of Health and Social Care. It includes amendments to the Human Medicines Regulations 2012 to facilitate vaccine administration, vaccine damage compensation provisions, and seasonal vaccination updates.
In response to: Supporting the delivery of COVID-19 and influenza vaccination
In response to: Supporting the delivery of COVID-19 and influenza vaccination
Seeks views on proposed changes to regulations 3A, 19 and 247A of the Human Medicines Regulations 2012 to support the ongoing delivery of COVID-19 and influenza vaccination.
Seeks views on proposed changes to regulations 3A, 19 and 247A of the Human Medicines Regulations 2012 to support the ongoing delivery of COVID-19 and influenza vaccination.
Seeks views on proposed changes to regulations 3A, 19 and 247A of the Human Medicines Regulations 2012 to support the ongoing delivery of COVID-19 and influenza vaccination.
In response to: Revoking vaccination as a condition of deployment across all health and social care
In response to: Making vaccination a condition of deployment in the health and wider social care sector
The government is seeking views on whether or not to extend vaccination requirements to other health and care settings for COVID-19 and also for flu.
The government is seeking views on whether or not to extend vaccination requirements to other health and care settings for COVID-19 and also for flu.
The government is seeking views on whether or not to extend vaccination requirements to other health and care settings for COVID-19 and also for flu.
In response to: Distributing vaccines and treatments for COVID-19 and flu
In response to: Distributing vaccines and treatments for COVID-19 and flu
We want your views on proposed changes to the Human Medicine Regulations to help with the safe and efficient distribution of a COVID-19 vaccine and expanded flu vaccine programme in the UK, along with treatments for COVID-19 and any other …
We want your views on proposed changes to the Human Medicine Regulations to help with the safe and efficient distribution of a COVID-19 vaccine and expanded flu vaccine programme in the UK, along with treatments for COVID-19 and any other …
We want your views on proposed changes to the Human Medicine Regulations to help with the safe and efficient distribution of a COVID-19 vaccine and expanded flu vaccine programme in the UK, along with treatments for COVID-19 and any other …
Consultation on the 2016 report into the cost effectiveness methodology for immunisation programmes and procurement (CEMIPP).
Consultation on the 2016 report into the cost effectiveness methodology for immunisation programmes and procurement (CEMIPP).
Consultation on the 2016 report into the cost effectiveness methodology for immunisation programmes and procurement (CEMIPP).
Consultation on the 2016 report into the cost effectiveness methodology for immunisation programmes and procurement (CEMIPP).
Seeks views on the revised code of practice for prevention and control of infections and the related guidance.
Seeks views on the revised code of practice for prevention and control of infections and the related guidance.
Seeks views on the revised code of practice for prevention and control of infections and the related guidance.